Skip to main content
. 2019 Jul 17;42(10):851–859. doi: 10.1002/clc.23231

Figure 2.

Figure 2

Global flow chart of the study population. AC, anticoagulant; AF, atrial fibrillation; VKA, vitamin‐K antagonist